Turning Point Therapeutics Names Andrew Partridge As Executive Vice President and Chief Commercial Officer

NEXT STORY
Global Environmental Testing Industry
PREV STORY
Phathom Pharmaceuticals Announces Appointment of Todd Branning as Chief Financial Officer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Radius Health to Announce Third Quarter 2017 Financial Results, Host Conference Call and Live Webcast on November 2, 2017

WALTHAM, Mass., Oct. 09, 2017 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq:RDUS) announced today that ...

author_avatar
NASDAQ Market News

Agios to Focus on Developing and Commercializing Innovative Treatments for Genetically Defined Diseases and Sell Its Oncology Business to Servier for Up to $2 Billion Plus Royalties

author_avatar
NASDAQ Market News

Breadth of data at ECTRIMS underpins Novartis’ relentless commitment to decoding the science of multiple sclerosis (MS) and decreasing the patient burden

33 abstracts from the leading MS portfolio include data for Gilenya® (fingolimod), and investigational ...

author_avatar
NASDAQ Market News